22.02.2010 • News

Schlumberger, Smith Don't See Antitrust Sales

Schlumberger and Smith International do not expect to have to sell any major assets to get antitrust clearance for the oilfield services leader's acquisition of Smith, a source familiar with the deal said on Sunday.

Schlumberger earlier on Sunday announced a deal to buy Smith in an all-stock deal that values the company at about $11.3 billion. Commenting after the Wall Street Journal reported on Friday that Schlumberger was in talks to buy Smith, analysts said government antitrust enforcers could give the deal a hard look.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read